South Florida Business Journal -- Bioheart reduced its losses in 2009 as it raised enough money to keep its products in development. The Sunrise-based biotechnology development company (OTCBB: BHRT) lost $3.8 million, or 21 cents a share, in 2009, improved from a net loss of $14.2 million, or 97 cents a share, in 2008, according to its Securities and Exchange Commission filing. The company reduced expenses by spending less on clinical trials. Bioheart also increased its revenue to $359,800from $57,051 in 2008.
